Creative Touch Permanent Makeup and Aesthetics

Glycation is not simply “sugar damaging collagen.” It is a self-amplifying cascade: glucose reacts with protein amino groups through the Maillard reaction to form reversible Schiff bases, which rearrange into more stable Amadori products, which progress irreversibly to AGEs. In dermal collagen, which is a tissue with extremely low turnover, glucosepane cross-links accumulate over decades, measurably stiffening fibril bundles. RAGE activation then adds a second injury layer: ROS generation, MMP-9 upregulation, NF-κB-driven inflammation, and melanogenesis signalling. Skin yellowing is driven by a specific yellow chromophore, AGEY, only recently identified in 2024. The process accelerates with repeated glucose spikes, not only with diagnosed diabetes.

Glycation is the spontaneous, non-enzymatic reaction between reducing sugars – primarily glucose, but also fructose, ribose, and methylglyoxal – and the free amino groups of proteins. Unlike enzymatic glycosylation, which is tightly controlled and functionally purposeful, glycation is a chemical inevitability wherever proteins and sugars coexist in biological tissue. The rate at which it occurs depends on ambient glucose concentration, temperature, pH, and crucially, how long the protein remains in tissue. This is why skin, with its relatively slow dermal protein turnover, accumulates glycation products substantially over time.

The Maillard Reaction in Skin

Glycation proceeds through a defined chemical sequence. The initial condensation of glucose with a lysine or arginine residue on a protein produces a reversible Schiff base. Over hours to days, this rearranges into a more stable but still reversible Amadori product. Over weeks to months, Amadori products undergo further oxidation, dehydration, and cyclisation reactions that produce the irreversible, heterogeneous family of molecules collectively termed advanced glycation end products (AGEs). ^[8]

The transition from reversible early-stage glycation to irreversible AGE formation is the critical threshold. Before AGE formation, improved glycaemic control can slow or partially reverse the process. After AGE formation in stable, slow-turnover proteins like dermal collagen, the modification is permanent for the life of that protein molecule. In dermal collagen, where the half-life of Type I collagen is measured in years to decades, that means the accumulation is effectively permanent without physical removal of the modified tissue. ^[8]

What AGEs Do to Dermal Structure

The primary structural consequence of AGE accumulation in dermal collagen is cross-linking: the formation of covalent bonds between adjacent collagen molecules that would not otherwise exist. The most abundant AGE cross-link in ageing human skin is glucosepane, a bulky cross-link formed between lysine and arginine residues on adjacent collagen chains. ^[8] Carboxymethyl-lysine (CML) is the most commonly measured AGE biomarker in skin collagen research; pentosidine is the primary fluorescent AGE and an established marker of cumulative glycation burden.

The mechanical consequence is measurable and specific. Atomic force microscopy of glycated collagen fibrils – both ex vivo in aged human dermis and in ribose-glycated organ culture models – demonstrates significantly increased fibril stiffness and hardness compared with young collagen, with no significant morphological change in fibril diameter or organisation. ^[4] The collagen is not degraded or fragmented; it is mechanically locked. Where healthy collagen yields slightly under compression and recovers elastically, heavily glycated collagen resists deformation and fails to rebound.

Severely cross-linked collagen also resists collagenase activity. The MMPs that ordinarily degrade and remodel collagen cannot process glycated fibrils effectively, causing further AGE accumulation in a self-reinforcing cycle. ^[8] Normal collagen turnover stalls. The dermis accumulates structurally rigid, enzymatically resistant material that cannot be replaced through normal remodelling.

Glycation affects elastin alongside collagen, reducing its elastic recoil. It also impairs fibroblast function through both the physical constraint of a stiffened ECM and through direct cellular mechanisms. Cultured fibroblasts exposed to glycated collagen produce shortened, thinned, and disorganised collagen fibrils of their own, and show reduced elasticity and contraction capacity. ^[7] The structural environment that fibroblasts receive shapes the structural product they can produce.

RAGE: The Second Injury

AGEs do not only accumulate passively. They bind to a cell-surface receptor, RAGE (Receptor for Advanced Glycation End products), expressed on fibroblasts, keratinocytes, melanocytes, and immune cells. RAGE activation generates a cascade of downstream consequences that operate independently of the structural cross-linking described above. ^[6]

RAGE ligation triggers rapid reactive oxygen species (ROS) generation and NF-κB activation, driving upregulation of pro-inflammatory cytokines, MMP-9, and further oxidative stress, which itself accelerates AGE formation through carbonylation pathways. ^[3] This is the self-amplifying loop: AGEs activate RAGE → RAGE drives ROS and inflammation → oxidative stress generates more AGEs → more RAGE activation. Once established, the cycle sustains itself independently of the original glucose trigger.

RAGE activation in melanocytes activates ERK and CREB signalling pathways, increasing MITF expression, tyrosinase activity, and melanin production, confirming that AGE accumulation contributes to hyperpigmentation through a receptor-mediated signalling route, not merely through passive yellowing. ^[5] Blocking RAGE eliminates this melanogenic response, establishing the pathway as causal rather than associative.

Why Skin Yellows

The visible skin yellowing associated with high glycation burden has been attributed historically to pentosidine and CML, but a 2024 study (Hotta et al.) using high-resolution analytical chemistry on native human epidermal explants identified a previously unknown yellow chromophore – designated AGEY – as the primary driver of skin yellowing. ^[2] AGEY showed a Pearson correlation of R = 0.72 with measured skin yellowness (b* value), significantly stronger than the other known AGEs, and formed in a dose-dependent manner under induced glycation conditions. CML and pentosidine, long assumed to carry the yellowing signal, are colourless.

This is a recent finding with significant implications. Skin yellowing is not simply a cosmetic incidental of glycation, it is a direct consequence of specific AGE chemistry that is now, for the first time, chemically characterised. It also provides a more precise biomarker target for anti-glycation intervention research than fluorescent pentosidine alone.

Rate and Acceleration

Glycation occurs at a background rate in all individuals, independent of diabetic status. What accelerates it is sustained elevation of blood glucose, not only at diabetic levels, but through the repeated post-prandial glucose spikes that accompany high glycaemic-index diets in metabolically normal individuals. Fructose glycates proteins approximately ten times faster than glucose at equivalent concentrations; methylglyoxal, a reactive dicarbonyl formed during glycolysis and particularly abundant in high-sugar metabolic environments, is among the most potent glycating agents in biological tissue. ^[8] The relationship between metabolic health and dermal glycation is therefore continuous rather than threshold-dependent: the more stable the blood glucose profile, the slower the AGE accumulation rate over decades of tissue lifetime.

There is a second, internally driven route that operates independently of dietary glucose intake. When cellular mitochondrial function declines – as occurs progressively with age and in response to chronic oxidative stress – cells shift from oxidative phosphorylation to glycolysis as their primary energy source. This metabolic shift elevates the flux of glycolytic intermediates, increasing intracellular methylglyoxal production. ^[1] A fibroblast with compromised mitochondrial function therefore accelerates its own AGE accumulation independently of blood glucose levels – a mechanism that connects dermal glycation to the broader pattern of mitochondrial decline in ageing skin, and explains why glycation burden can advance even in clients with well-managed diets.